Pollock, Carol

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 6,189

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results From the Randomized CREDENCE Trial

Mahaffey, K. W., Jardine, M. J., Bompoint, S., Cannon, C. P., Neal, B., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., et al. (2019) · Circulation

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 291

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study rationale, design, and baseline characteristics

Jardine, M. J., Mahaffey, K. W., Neal, B., Agarwal, R., Bakris, G. L., Brenner, B. M., Bull, S., Cannon, C. P., Charytan, D. M., de Zeeuw, D., et al. (2017) · American Journal of Nephrology

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 234

Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial

Doig, G. S., Simpson, F., Bellomo, R., Heighes, P. T., Sweetman, E. A., Chesher, D., Pollock, C., Davies, A., Botha, J., Harrigan, P., et al. (2015) · Intensive Care Medicine

Acute Kidney Injury ResearchClinical Nutrition and Gastroenterology

Cited by 232

Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial

Pollock, C., Stefánsson, B., Reyner, D., Rossing, P., Sjöström, C. D., Wheeler, D. C., Langkilde, A. M., & Heerspink, H. J. L. (2019) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 205

Early change in albuminuria with canagliflozin predicts kidney and cardiovascular outcomes: a post hoc analysis from the CREDENCE Trial

Oshima, M., Neuen, B. L., Li, J., Perkovic, V., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Levin, A., Mahaffey, K. W., et al. (2020) · Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 176

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

Oshima, M., Jardine, M. J., Agarwal, R., Bakris, G., Cannon, C. P., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Levin, A., et al. (2021) · Kidney International

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 166

Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2: Subgroup Analysis of the Randomized CREDENCE Trial

Bakris, G., Oshima, M., Mahaffey, K. W., Agarwal, R., Cannon, C. P., Capuano, G., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., et al. (2020) · Clinical Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 142

Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway

Huang, C., Zhang, Y., Kelly, D. J., Tan, C. Y. R., Gill, A., Cheng, D., Braet, F., Park, J.-S., Sue, C. M., Pollock, C. A., et al. (2016) · Scientific Reports

Autophagy in Disease and TherapyChronic Kidney Disease and Diabetes

Cited by 136

Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial

Oshima, M., Neuen, B. L., Jardine, M. J., Bakris, G., Edwards, R., Levin, A., Mahaffey, K. W., Neal, B., Pollock, C., Rosenthal, N., et al. (2020) · The Lancet Diabetes & Endocrinology

Erythropoietin and Anemia TreatmentDiabetes Treatment and Management

Cited by 135

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial

Cannon, C. P., Perkovic, V., Agarwal, R., Baldassarre, J., Bakris, G., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Heerspink, H. J. L., et al. (2020) · Circulation

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 117

Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial

Ye, N., Jardine, M. J., Oshima, M., Hockham, C., Heerspink, H. J. L., Agarwal, R., Bakris, G., Schutte, A. E., Arnott, C., Chang, T. I., et al. (2021) · Circulation

Blood Pressure and Hypertension StudiesDiabetes Treatment and Management

Cited by 115

Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury

Birtwistle, L., Chen, X.-M., & Pollock, C. (2021) · International Journal of Molecular Sciences

Extracellular vesicles in diseaseMesenchymal stem cell research

Cited by 113

TGF-β1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway

Qi, W., Chen, X., Polhill, T. S., Sumual, S., Twigg, S., Gilbert, R. E., & Pollock, C. A. (2006) · American Journal of Physiology-Renal Physiology

Connective Tissue Growth Factor ResearchTGF-β signaling in diseases

Cited by 97

Maternal obesity increases the risk of metabolic disease and impacts renal health in offspring

Glastras, S. J., Chen, H., Pollock, C. A., & Saad, S. (2018) · Bioscience Reports

Birth, Development, and HealthPregnancy and preeclampsia studies

Cited by 83

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes

Neuen, B. L., Arnott, C., Perkovic, V., Figtree, G., de Zeeuw, D., Fulcher, G., Jun, M., Jardine, M. J., Zoungas, S., Pollock, C., et al. (2021) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 78

Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes

Gangadharan Komala, M., Gross, S., Zaky, A., Pollock, C., & Panchapakesan, U. (2016) · Nephrology

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 68

High glucose and endothelial cell growth: novel effects independent of autocrine TGF-β1 and hyperosmolarity

McGinn, S., Poronnik, P., King, M., Gallery, E. D. M., & Pollock, C. A. (2003) · American Journal of Physiology-Cell Physiology

TGF-β signaling in diseasesNitric Oxide and Endothelin Effects

Cited by 63

Impact of maternal e-cigarette vapor exposure on renal health in the offspring

Li, G., Chan, Y. L., Nguyen, L. T., Mak, C., Zaky, A., Anwer, A. G., Shi, Y., Nguyen, T., Pollock, C. A., Oliver, B. G., et al. (2019) · Annals of the New York Academy of Sciences

Prenatal Substance Exposure EffectsSmoking Behavior and Cessation

Cited by 50

Review article: Importance of the kidney proximal tubular cells in thiazolidinedione-mediated sodium and water uptake

PANCHAPAKESAN, U., POLLOCK, C., & SAAD, S. (2009) · Nephrology

Ion Transport and Channel RegulationPeroxisome Proliferator-Activated Receptors

Cited by 25

Sirtuins-Mediators of Maternal Obesity-Induced Complications in Offspring?

Nguyen, L. T., Chen, H., Pollock, C. A., & Saad, S. (2016) · The FASEB Journal

Sirtuins and Resveratrol in MedicineBirth, Development, and Health

Cited by 19